Shengli Xue Selected Research

Myelodysplastic Syndromes (Myelodysplastic Syndrome)

1/2024	Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective study.
1/2022	Prognostic impact of Auer rods for cytoreductive chemotherapy and myeloablative allogeneic stem cell transplantation in adult patients with myelodysplastic syndrome with excess blasts-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shengli Xue Research Topics

Disease

10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2023 - 02/2014
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 07/2014
5	Leukemia 01/2023 - 07/2014
3	Philadelphia Chromosome 10/2023 - 02/2014
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 01/2016
3	Neoplasms (Cancer) 01/2023 - 01/2003
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2024 - 01/2022
2	Multiple Myeloma 01/2022 - 10/2013
1	Critical Illness (Critically Ill) 01/2024
1	COVID-19 10/2023
1	Viremia 10/2023
1	Residual Neoplasm 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Blast Crisis (Blast Phase) 01/2023
1	Epstein-Barr Virus Infections 02/2016
1	POEMS Syndrome (Syndrome, POEMS) 12/2009
1	Hepatocellular Carcinoma (Hepatoma) 01/2003

Drug/Important Bio-Agent (IBA)

6	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2022
4	venetoclaxIBA 01/2024 - 01/2023
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 02/2016 - 01/2016
2	Therapeutic UsesIBA 10/2013 - 11/2011
1	Core Binding Factors (Core-Binding Factor)IBA 10/2023
1	SteroidsIBA 01/2023
1	Basiliximab FDA Link 01/2023
1	ruxolitinibIBA 01/2023
1	olverembatinibIBA 01/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2020
1	AclarubicinIBA 12/2020
1	Decitabine FDA Link 12/2020
1	Complementary DNA (cDNA)IBA 03/2018
1	Imatinib Mesylate (Gleevec)FDA Link 02/2014
1	Bortezomib (Velcade)FDA Link 12/2009
1	EndostatinsIBA 01/2003
1	Recombinant ProteinsIBA 01/2003

Therapy/Procedure

13	Hematopoietic Stem Cell Transplantation 01/2024 - 10/2013
5	Therapeutics 10/2023 - 02/2014
4	Transplantation 10/2023 - 07/2014
3	Stem Cell Transplantation 10/2023 - 08/2021
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
2	Salvage Therapy 01/2023 - 12/2020
1	Induction Chemotherapy 12/2023
1	Bridge Therapy 01/2023